A quality improvement initiative to improve management of procedural pain in preterm neonates

16/07/42 Background: Neonates managed in neonatal intensive care units undergo several invasive procedures. However, neonatal procedural pain is not well recognized and managed in most neonatal units.

Aims: To decrease the severity of procedural pain in preterm neonates (37 weeks gestational age at birth), as measured by Premature Infant Pain Profile , by 50% by April 2020.

Methods: A quality improvement initiative was conducted in a level 3 neonatal intensive care unit in South India. The pain was assessed independently by 2 interns not involved in clinical care using Premature Infant Pain Profile. After a baseline data recording and questionnaire assessing knowledge of healthcare personnel regarding neonatal pain, the interventions were planned. These were conducted as plan-do-study-act cycles-(i) Educational sessions, (ii) Introduction of bedside visual aids, (iii) Simulation sessions demonstrating the use of nonpharmacological measures and introduction of procedure surveillance chart in daily rounds, and (iv) Video feedback-based sessions. In the maintenance phase, the observations were continued.

Results: The healthcare personnel under recognized pain related to heel pricks and endotracheal intubation. They also had poor awareness of signs and symptoms of neonatal pain. A total of 202 procedures were observed during the study period. The mean pain score decreased significantly from 12.8 ± 4.5 in baseline period to 6.2 ± 1.8 in the maintenance phase. The use of analgesic measures increased from 13% in the baseline period to 73% in the maintenance phase. The use of automated lancet for heel prick increased from 0% to 94% in maintenance phase. More and more procedures were done with appropriate environment and baby state. The mean number of procedures per day decreased from 6.5 ± 1.8 in baseline period to 2.7 ± 0.9 in the maintenance phase.

Conclusions: Targeted interventions can improve neonatal procedural pain management by improving use of analgesic measures, decreasing the number of procedures, and educating and training healthcare personnel.



Kirenol: A promising bioactive metabolite from siegesbeckia species: A detailed review

اكتشف المزيد


Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches

اكتشف المزيد


Nitric-Oxide-Mediated Vasodilation of Bioactive Compounds Isolated from Hypericum revolutum in Rat Aorta

اكتشف المزيد


Natural Products of the Fungal Genus Humicola: Diversity, Biological Activity, and Industrial Importance

اكتشف المزيد


Jojoba oil: An updated comprehensive review on chemistry, pharmaceutical uses, and toxicity

اكتشف المزيد


Vasodilating effect of Hypericum revolutum (Vahl) (Clusiaceae) methanol extract in rats

اكتشف المزيد

سياسة ملفات الارتباط

ايستخدم هذا الموقع ملفات تعريف الارتباط لتحسين تجربة المستخدم الخاصة بك. من خلال القبول والإغلاق عند زيارة الصفحة لأول مرة ، فإنك توافق على استخدامنا لملفات تعريف الارتباط